ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Technology

Kobayashi Pharmaceutical Co., Ltd.

Business Summary

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.

Financial Highlights

Dec 2020 JPYUSD
Revenue150,514M1,409.72M
Gross Profit84,125M787.91M
Operating income25,809M241.72M
Income before tax26,635M249.46M
Net income19,205M179.87M
EBITDA29,915M280.18M
Diluted EPS245.702.30
Dividends Per Share770.72
Total Assets238,366M2,308.74M
Total liabilities55,781M540.27M
Total equity182,583M1,768.44M
Operating cash flow23,986M224.65M
Currency in JPYCurrency in USD

Historical Data

 Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020
Revenue 160,067.59M 156,761M 167,479M 158,340M 150,514M
Gross Profit 93,833.09M 94,189M 101,963M 89,689M 84,125M
Operating income 23,097.27M 22,809M 26,191M 25,512M 25,809M
Income before tax 26,402.60M 22,572M 25,304M 26,804M 26,635M
Net income 19,094.61M 15,863M 18,023M 19,139M 19,205M
EBITDA 26,598.60M 26,328M 29,594M 29,639M 29,915M
Diluted EPS 237.21 201.02 227.95 244.07 245.70
Dividends Per Share 100 58 66 73 77
Total Assets 201,234M 218,831M 228,787M 233,732M 238,366M
Total liabilities 57,914M 65,016M 62,536M 61,072M 55,781M
Total equity 143,320M 153,811M 166,249M 172,657M 182,583M
Operating cash flow 16,097M 22,350M 20,007M 20,089M 23,986M
 Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020
Revenue 1,473.12M 1,397.98M 1,516.43M 1,452.51M 1,409.72M
Gross Profit 863.55M 839.97M 923.21M 822.75M 787.91M
Operating income 212.56M 203.40M 237.14M 234.03M 241.72M
Income before tax 242.98M 201.29M 229.11M 245.88M 249.46M
Net income 175.72M 141.46M 163.18M 175.56M 179.87M
EBITDA 244.78M 234.79M 267.95M 271.89M 280.18M
Diluted EPS 2.18 1.79 2.06 2.23 2.30
Dividends Per Share 0.92 0.51 0.59 0.66 0.72
Total Assets 1,725.33M 1,942.57M 2,085.28M 2,150.74M 2,308.74M
Total liabilities 496.54M 577.15M 569.98M 561.96M 540.27M
Total equity 1,228.79M 1,365.38M 1,515.28M 1,588.74M 1,768.44M
Operating cash flow 148.14M 199.31M 181.15M 184.28M 224.65M

Valuation Measures

Dec 2020
PER51.32
ROA8.13%
ROE10.81%
Operating margin17.14%
Profit margin12.75%

Key executives

  • President & Representative Director: Akihiro Kobayashi
  • Manager-Finance & Accounting: Noriaki Hirao
  • Executive Officer & General Manager-Manufacturing: Tetsuji Nishioka
  • Executive Officer & Manager-Healthcare Business: Fujito Owaki
  • Executive Officer & Manager-Mail Order Sales: Yoshihiro Ogawa

Shareholders

  • KOBAYASHI AKIHIRO /KOBAYASHI PHARMACEUTICAL/ (11.2%)
  • Kobayashi Foundation (7.3%)
  • MFS International (UK) Ltd. (5.4%)
  • Kobayashi Pharmaceutical Co., Ltd. (4.7%)
  • WATANABE IKUKO (2.9%)
  • Ohtori Ltd. (2.6%)
  • MIYATA FAMILY /KOBAYASHI PHARMACEUTICAL/ (2.5%)
  • IUE YUKAKO (2.2%)
  • Nomura Asset Management Co., Ltd. (2.2%)
  • Kobayashi Pharmaceutical Business Association (1.8%)

Contact Details

  • Website:http://www.kobayashi.co.jp
  • Address: KDX Kobayashi Doshomachi Building, 4-4-10 Dosho-machi, Osaka, 541-0045, Japan
  • Phone: +81.6.6231.1144

Related Companies

  • Jiangsu Kobayashi Pharmaceutical Co. Ltd.
  • True Nature KK
  • Kobayashi Pharmaceutical Aoitori Foundation
  • Kobayashi America Manufacturing LLC
  • Hefei Kobayashi Daily Chemicals Co. Ltd.
  • PT Kobayashi Pharmaceutical Indonesia
  • Kobayashi Healthcare LLC
  • Kobayashi Healthcare (Malaysia) Sdn. Bhd.
  • Kobayashi Pharmaceutical (Taiwan) Co. Ltd.
  • Kobayashi Healthcare of America, Inc.
  • Shanghai Kobayashi Pharmaceutical Business Co. Ltd.
  • Hefei Kobayashi Daily Products Co. Ltd.
  • KOBAYASHI Healthcare (Thailand) Co. Ltd.
  • PT Kobayashi Eglin
  • KOBAYASHI Pharmaceutical (Singapore) Pte Ltd.
  • Kobayashi Pharmaceutical (Hong Kong) Co. Ltd.
  • Kobayashi Healthcare Australia Pty Ltd.
  • Kobayashi Healthcare Europe Ltd.
  • Rokuyou-Seiyaku, Inc.
  • Kobayashi Medical America LLC
  • Meitan Hompo KK
  • Kobayashi Pharmaceutical Business Association
  • Ehime Kobayashi Pharmaceutical Co. Ltd.
  • Kobayashi Pharmaceutical Distribution Co. Ltd.
  • Kobayashi Pharmaceutical Plax Co. Ltd.
  • Suehiro Sangyo Co. Ltd.
  • Kobayashi Pharmaceutical of Toyama Co. Ltd.
  • Sendai Kobayashi Pharmaceutical Co. Ltd.
  • Juju Cosmetics Co., Ltd.
  • Heatmax, Inc.

Competitors

    Last Updated on 17 Sep, 2021

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

    Stay ahead with our exclusives on Asia;
    the most dynamic market in the world.

    Stay ahead with our exclusives on Asia

    Get trusted insights from experts within Asia itself.

    Get trusted insights from experts
    within Asia itself.

    Try 1 month for $0.99

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

    This is your last free article this month

    Stay ahead with our exclusives on Asia; the most
    dynamic market in the world
    .

    Get trusted insights from experts
    within Asia itself.

    Try 3 months for $9

    Offer ends July 31st

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to Nikkei Asia has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more